Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | IMPDH2 | P12268 | 10/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | IMPDH1 | P20839 | 5/20 | 0.40 |
| ▸ | FHIT | P49789 | 2/20 | 0.40 |
| ▸ | NADK | O95544 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24444131 | 0.92 | ADH1A (0.43) | BCHEIMPDH2ADH1AIMPDH1NADK | |
| SCHEMBL24258564 | 0.89 | IMPDH2 (0.46) | IMPDH2ADH1AIMPDH1FHITNADK | |
| SCHEMBL21263919 | 0.87 | FHIT (0.41) | BCHEIMPDH2ADH1AIMPDH1FHIT | |
| SCHEMBL21263869 | 0.81 | AHCY (0.43) | IMPDH2ADH1AIMPDH1FHITNADK | |
| SCHEMBL22571145 | 0.79 | BCHE (0.53) | BCHEFHIT | |
| SCHEMBL24258561 | 0.79 | BCHE (0.42) | BCHEFHIT | |
| SCHEMBL24258672 | 0.76 | TAS1R3 (0.41) | IMPDH2ADH1AIMPDH1NADK | |
| SCHEMBL22524142 | 0.76 | BCHE (0.55) | BCHE | |
| SCHEMBL22524006 | 0.76 | P2RY1 (0.56) | BCHE | |
| SCHEMBL21540024 | 0.76 | P2RY1 (0.56) | BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752516-B1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2022-02-23 | — | — | EP | disclosed |